Literature DB >> 9009994

Thalamic haemorrhage.

C S Chung1, L R Caplan, W Han, M S Pessin, K H Lee, J M Kim.   

Abstract

Thalamic haemorrhage is usually considered a single entity although the thalamus is composed of anatomically as well as functionally discrete subregions receiving blood from different arteries. The clinical features vary according to the intrathalamic location of the haematomas and the bleeding artery. We investigated the impact of haematoma location and vascular territory on the clinical symptoms and signs, neuro-imaging findings and clinical courses of patients with thalamic haemorrhages by a retrospective analysis of 175 consecutive patients with thalamic haemorrhage. Based on the neuro-imaging findings we classified thalamic haematomas into four regional types and one global type according to the primary bleeding sites: (i) anterior type occurring in the territory of the tuberothalamic arteries, (ii) posteromedial type occurring in the territory of the thalamic-subthalamic paramedian arteries, (iii) posterolateral type occurring in the territory of the thalamogeniculate arteries. (iv) dorsal type occurring in the territory of the posterior choroidal arteries and (v) global type occupying the entire area of the thalamus. We studied the clinical and neuroimaging characteristics of each type. Eleven patients (7%) had the anterior type: these were the smallest haematomas and often ruptured into the anterior horn of the lateral ventricle. The major clinical signs were acute behavioural abnormalities: the clinical course was usually benign. Twenty-four patients (14%) had the posteromedial type in which haematomas often ruptured into the third ventricle, causing marked hydrocephalus, and often extended mediocaudally, involving the mesencephalon. The prognoses of this type depended on the presence of mesencephalic involvement which was associated with the worst outcome among the types even if the size of the haematoma itself was not large. The posterolateral type was most frequent (77 patients, 44%) and was characterized by large haematomas, rupture into the posterior horn of the lateral ventricle and frequent extension into the posterior limb of the internal capsule. Clinical signs included marked sensory and motor signs, hemineglect in right-side haematomas and language abnormalities with left-side haematomas. The case fatality with this type was relatively high (35%) and permanent neurologic sequelae frequently resulted. In the dorsal type (32 patients, 18%) haematomas were best visualized at the level of the body of the lateral ventricle on CT scans. The size was moderate and haematomas often extended posterolaterally into the adjacent subcortical white matter. Sensory and motor signs were common and about one third of the patients were first misdiagnosed as having lacunar infarcts. The prognoses were excellent. The global type (31 patients, 18%) of thalamic haemorrhage was clinically and radiologically very similar to the posterolateral type except that the haematomas were too large to define the bleeding focus. Severe sensory and motor signs were almost always present. In this type 25 patients died (the case fatality was 81%).

Entities:  

Mesh:

Year:  1996        PMID: 9009994     DOI: 10.1093/brain/119.6.1873

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

1.  Atypical presentation of thalamic post-stroke pain.

Authors:  Francesco Brigo; Fabio Rossini; Ambra Stefani; Pierluigi Tocco; Antonio Fiaschi; Alessandro Salviati
Journal:  Neurol Sci       Date:  2012-07-25       Impact factor: 3.307

2.  Defining the Optimal Midline Shift Threshold to Predict Poor Outcome in Patients with Supratentorial Spontaneous Intracerebral Hemorrhage.

Authors:  Wen-Song Yang; Qi Li; Rui Li; Qing-Jun Liu; Xing-Chen Wang; Li-Bo Zhao; Peng Xie
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

3.  Gabapentinoid Insensitivity after Repeated Administration is Associated with Down-Regulation of the α(2)δ-1 Subunit in Rats with Central Post-Stroke Pain Hypersensitivity.

Authors:  Yan Yang; Fei Yang; Fan Yang; Chun-Li Li; Yan Wang; Zhen Li; Yun-Fei Lu; Yao-Qing Yu; Han Fu; Ting He; Wei Sun; Rui-Rui Wang; Jun Chen
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

Review 4.  Thalamic Lesions and Aphasia or Neglect.

Authors:  Shinichiro Maeshima; Aiko Osawa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

5.  Post-stroke pain hypersensitivity induced by experimental thalamic hemorrhage in rats is region-specific and demonstrates limited efficacy of gabapentin.

Authors:  Fei Yang; Han Fu; Yun-Fei Lu; Xiao-Liang Wang; Yan Yang; Fan Yang; Yao-Qing Yu; Wei Sun; Jia-Shuang Wang; Michael Costigan; Jun Chen
Journal:  Neurosci Bull       Date:  2014-11-05       Impact factor: 5.203

6.  Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area.

Authors:  Seung-Hoon Lee; Seon-Joo Kwon; Ki Soon Kim; Byung-Woo Yoon; Jae-Kyu Roh
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 7.  Clinical Features of Thalamic Stroke.

Authors:  Xiang Yan Chen; Qiaoshu Wang; Xin Wang; Ka Sing Wong
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

8.  Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome.

Authors:  Homajoun Maslehaty; Athanasios K Petridis; Harald Barth; Alexandros Doukas; Hubertus Maximilian Mehdorn
Journal:  Clin Pract       Date:  2012-05-17

9.  Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.

Authors:  Aude Castel; Pierre Hélie; Francis Beaudry; Pascal Vachon
Journal:  BMC Vet Res       Date:  2013-03-27       Impact factor: 2.741

10.  Thalamic haemorrhage vs internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality.

Authors:  Adrià Arboix; Raquel Rodríguez-Aguilar; Montserrat Oliveres; Emili Comes; Luis García-Eroles; Joan Massons
Journal:  BMC Neurol       Date:  2007-10-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.